Linda Lebon

General Counsel at OSE IMMUNOTHERAPEUTICS

60 year

Health Technology

Consumer Services

Profile

Linda Lebon is currently the Chief Regulatory Officer at OSE Immunotherapeutics SA since 2021.
Prior to this, she worked as the Chief Regulatory Officer at Bone Therapeutics SA from 2018 to 2021.
Before that, she held the position of Vice President-Regulatory Affairs at argenx SE and Director-Regulatory Affairs at iTeos Therapeutics SA. Ms. Lebon holds an MBA from École des Hautes Études Commerciales de Paris and a graduate degree from Centre Hospitalier Universitaire de Liege.

Linda Lebon active positions

Companies	Position	Start
OSE IMMUNOTHERAPEUTICS	General Counsel	20/12/2021

All active positions of Linda Lebon

Former positions of Linda Lebon

Companies	Position	End
BIOSENIC SA	General Counsel	01/09/2021
ARGENX SE	General Counsel	-
iTeos Therapeutics SA iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy	General Counsel	-

See the detail of Linda Lebon's experience

Training of Linda Lebon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Linda Lebon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
École des Hautes Études Commerciales de Paris École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
argenx SE argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases	Health Technology
Bone Therapeutics SA Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops regenerative therapy products for addressing unmet medical needs in the field of bone diseases and orthopedics	Health Technology
iTeos Therapeutics SA iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy	Health Technology
Centre Hospitalier Universitaire de Liege Centre Hospitalier Universitaire de Liege Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
OSE Immunotherapeutics SA OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers	Health Technology